Clinical Trial Update: Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing the safety of ovarian function suppression (OFS) combined with AI endocrine therapy in Chinese premenopausal breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• OFS combined with AI endocrine therapy (OFS + AI endocrine therapy)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED